Uptake of testing for BRCA1/2 mutations in South East Scotland
Open Access
- 20 February 2008
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 16 (8) , 906-912
Abstract
We investigated the uptake of genetic testing by 54 families in South East Scotland with a BRCA1/2 mutation. At a median of 37 months since identification of the mutation, the overall rate of uptake of testing in 269 eligible family members was 32%. First-degree relatives were significantly (Pversus 68%). Among relatives who attended for genetic counselling, females were more likely to be tested than males (76 versus 53%; Pversus 53%; Pversus 36.8 years, P<0.05) but did not differ in degree of relationship to the index case or in socioeconomic deprivation. Our results confirm the findings from other studies of substantially lower rates of uptake of genetic testing for BRCA1/2 mutations than anticipated in earlier predictions. Relatives in more socioeconomically deprived families were less likely to be referred for genetic counselling, which is a matter of concern. This may be partly the result of a lack of understanding of the testing process. Cascading currently does not work in breast cancer families and further work is required to investigate intrafamilial communication patterns, testing behaviour and counselling strategies.Keywords
This publication has 16 references indexed in Scilit:
- Sharing BRCA1/2 Test Results With First-Degree Relatives: Factors Predicting Who Women TellJournal of Clinical Oncology, 2006
- Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian CancerJAMA, 2005
- BRCA1/2 predictive testing: a study of uptake in two centresEuropean Journal of Human Genetics, 2004
- Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical CohortGenetic Testing, 2004
- How families communicate about HNPCC genetic testing: Findings from a qualitative studyAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2003
- Psychosocial aspects of cancer genetics: Women at high risk for breast and ovarian cancerSeminars in Surgical Oncology, 2000
- Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationThe Lancet, 2000
- Attitudes to genetic testing for breast cancer susceptibility in women at increased risk of developing hereditary breast cancerJournal of Medical Genetics, 2000
- Decision-Making About Genetic Testing Among Women at Familial Risk for Breast CancerPsychosomatic Medicine, 1997
- Interest in genetic testing among first‐degree relatives of breast cancer patientsAmerican Journal of Medical Genetics, 1995